Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Ozempic, Wegovy Kidney Side Effects Highlighted in New Study The study’s findings add to growing concerns about the popular diabetes and weight loss drug’s effects on the kidneys. October 10, 2025 Irvin Jackson Add Your Comments A new study warns that side effects of Ozempic and Wegovy appear to be linked to an increased risk of kidney injuries, while their competitors, Mounjaro and Zepbound, are not. According to findings published in Preprints.org (PDF) on October 2, there have been a “disproportionate” number of acute kidney injuries (AKIs) among users of the popular weight loss and diabetes drugs, following a review of reports submitted to the U.S. Food and Drug Administration’s (FDA) Adverse Event Reporting System (FAERS). The findings have not yet been peer-reviewed and officially published. The drugs all belong to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists, the most popular of which is Ozempic (semaglutide), which was originally approved in 2017 for the treatment of type 2 diabetes. After the medications weight loss benefits led to widespread off-label use of Ozempic, the drug maker introduced a version under the brand name Wegovy, which contains the same active ingredient, but is approved as a diet drug. Eli Lilly’s competing drug, Mounjaro (tirzepatide), is also approved for diabetes treatment, with a weight loss counterpart marketed as Zepbound. Other drugs in the GLP-1 class include Saxenda, Byetta, Victoza, Trulicity, Rybelsus and others. As popularity of the drugs has soared over the past few years, concerns have emerged about a number of side effects being reported among users, particularly involving gastrointestinal problems like stomach paralysis and bowel obstructions, as well as vision loss. However, while many of these problems are class-wide, some side effects appear to be specific to particular drugs. As a result, the manufacturers have faced a growing number of Ozempic lawsuits, Mounjaro lawsuits, Wegovy lawsuits and other GLP-1 claims, each raising similar allegations that in the drug makers’ rush to promote the benefits associated with the treatments, they failed to adequately disclose potentially serious side effects some users experience. Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION Find Out If You Have a Lawsuit Were you prescribed Ozempic, Wegovy or Mounjaro? Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects Learn More SEE IF YOU QUALIFY FOR COMPENSATION In the new study, Dr. Ayush Gandhi of the University of Texas conducted a retrospective pharmacovigilance analysis using FAERS data from January 2022 through September 2025, identifying reports where the drugs were listed as the primary suspect in cases of acute kidney injury, renal failure, renal impairment, and other kidney-related complications. Although Mounjaro and Zepbound were associated with more than twice as many adverse event reports as Ozempic and Wegovy, the rate of acute kidney injury (AKI) was actually lower. According to the data: Mounjaro and Zepbound (tirzepatide): 92,807 total U.S. adverse event reports 432 involved AKI, accounting for 0.47% of cases Ozempic and Wegovy (semaglutide): 41,065 total U.S. adverse event reports 440 involved AKI, accounting for 1.07% of cases — more than double the AKI rate of tirzepatide According to the findings, there were 16 deaths, six disabilities, 11 life-threatening events, and 209 hospitalizations linked to Eli Lilly’s drugs. Comparatively, there were 28 deaths, 11 disabilities, 36 life-threatening events, and 243 hospitalizations linked to semaglutide. The number of reported adverse events typically only account for a fraction of actual side effects users are experiencing. “In summary, semaglutide continues to show a disproportionate signal for AKI in FAERS, while tirzepatide does not. Although absolute risk is low, the signal supports careful hydration counseling and monitoring for patients starting semaglutide.” – Dr. Ayush Gandhi, Department of Medicine, University of Texas The findings come on the heels of a study published in late August in JAMA Oncology, which warned that the entire class of GLP-1 medications could increase kidney cancer risks by more than a third. GLP-1 Side Effects Lawsuits The studies have been published amid more than 2,800 product liability lawsuits brought throughout the federal court system, each indicating GLP-1 manufacturers failed to provide adequate warning that the diabetes and weight loss drugs could cause severe gastrointestinal problems. Given common questions of fact and law raised throughout the complaints, all GLP-1 lawsuits have been centralized in a multidistrict litigation (MDL) in the Eastern District of Pennsylvania, where U.S. District Judge Karen Marston is overseeing coordinated discovery and pretrial proceedings. As part of that process, the court will eventually select a small group of representative cases to serve as early “bellwethers,” providing insight into how juries may respond to recurring evidence and testimony. First, however, Judge Marston has ordered both sides to resolve several issues that could have broad implications for the litigation, including preemption and general causation. Once those matters are addressed, the MDL is expected to proceed with preparing the first set of cases for jury consideration. While the verdicts will not directly determine the outcome of other GLP-1 claims, they are likely to shape settlement negotiations. If the parties do not reach a GLP-1 settlement agreement after the bellwether trials, Judge Marston is likely to begin remanding the cases back to their original courts for individual trial dates. Find Out If You Qualify for Ozempic or Wegovy Compensation Tags: Acute Kidney Injury, Bowel Obstruction, Diabetes Drugs, Eli Lilly, Gastroparesis, GLP-1, Kidney Cancer, Mounjaro, Novo Nordisk, Ozempic, Wegovy, Weight Loss Drug, Zepbound Image Credit: mikeledray / Shutterstock.com Written By: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. More Ozempic, Wegovy and Mounjaro Stories Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues October 28, 2025 Ozempic Gastroparesis Problems Persisted After Injections Stopped, Lawsuit Alleges October 21, 2025 Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue October 7, 2025 0 Comments CompanyThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Talc Powder Cancer Verdicts and Lawsuits Continue To Pile Up Against Johnson & Johnson (Posted: today) A Florida jury has ordered Johnson & Johnson to pay $20 million to the family of a man who died of mesothelioma after using the company’s talc-based products for 50 years. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSJ&J Faces Talcum Powder Lawsuit in UK Brought By More Than 3,000 Plaintiffs (10/17/2025)Lawyers in Talcum Powder Bellwether Lawsuit To Meet for Final Pretrial Conference Nov. 5 (10/10/2025)Jury Awards $966M in Baby Powder Wrongful Death Lawsuit Over Mesothelioma Diagnosis (10/08/2025) Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (Posted: yesterday) Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns. MORE ABOUT: DUPIXENT LAWSUITDupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025)Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025) Studies Highlight How Sports Betting Apps Cause Compulsive Gambling Addiction (Posted: 2 days ago) Researchers warn that sports-betting apps use reward-based design and constant engagement tactics that can fuel addiction among young adults—sparking a surge of lawsuits accusing major platforms of exploiting these vulnerabilities for profit. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITGambling Addiction Treatment Needs Surge Amid Sports Betting App Promotions (10/22/2025)Gambling Livestreams May Be Harming Young Adults: Study (10/16/2025)DraftKings Faces Lawsuit Over Failure To Design Sports Betting Website for Gamblers Disabilities (09/29/2025)
Lawsuits Over Vision Loss From Ozempic, Mounjaro Should Be Sent to New MDL Judge, Plaintiffs Argue October 7, 2025
Talc Powder Cancer Verdicts and Lawsuits Continue To Pile Up Against Johnson & Johnson (Posted: today) A Florida jury has ordered Johnson & Johnson to pay $20 million to the family of a man who died of mesothelioma after using the company’s talc-based products for 50 years. MORE ABOUT: TALCUM POWDER CANCER LAWSUITSJ&J Faces Talcum Powder Lawsuit in UK Brought By More Than 3,000 Plaintiffs (10/17/2025)Lawyers in Talcum Powder Bellwether Lawsuit To Meet for Final Pretrial Conference Nov. 5 (10/10/2025)Jury Awards $966M in Baby Powder Wrongful Death Lawsuit Over Mesothelioma Diagnosis (10/08/2025)
Dupixent Sales Surge Amid Growing CTCL Cancer Lawsuit Allegations (Posted: yesterday) Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns. MORE ABOUT: DUPIXENT LAWSUITDupixent Lawyers To Meet With Court for Initial Conference in T-Cell Lymphoma Lawsuit (10/17/2025)Dupixent Cancer Risks Outlined in User Stories, as Evidence Mounts of T-Cell Lymphoma Link (10/08/2025)Dupixent Wrongful Death Lawsuit Filed Over T-Cell Lymphoma Diagnosis (10/02/2025)
Studies Highlight How Sports Betting Apps Cause Compulsive Gambling Addiction (Posted: 2 days ago) Researchers warn that sports-betting apps use reward-based design and constant engagement tactics that can fuel addiction among young adults—sparking a surge of lawsuits accusing major platforms of exploiting these vulnerabilities for profit. MORE ABOUT: SPORTS BETTING ADDICTION LAWSUITGambling Addiction Treatment Needs Surge Amid Sports Betting App Promotions (10/22/2025)Gambling Livestreams May Be Harming Young Adults: Study (10/16/2025)DraftKings Faces Lawsuit Over Failure To Design Sports Betting Website for Gamblers Disabilities (09/29/2025)